Nutraceutical International (Nutraceutical International) Debt-to-Equity : 0.28 (As of Jun. 2017)

View and export this data going back to 1998. Start your Free Trial

What is Nutraceutical International Debt-to-Equity?

Nutraceutical International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2017 was $0.0 Mil. Nutraceutical International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2017 was $50.5 Mil. Nutraceutical International's Total Stockholders Equity for the quarter that ended in Jun. 2017 was $182.2 Mil. Nutraceutical International's debt to equity for the quarter that ended in Jun. 2017 was 0.28.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Nutraceutical International's Debt-to-Equity or its related term are showing as below:

NUTR's Debt-to-Equity is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 0.41
* Ranked among companies with meaningful Debt-to-Equity only.

Nutraceutical International Debt-to-Equity Historical Data

The historical data trend for Nutraceutical International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutraceutical International Debt-to-Equity Chart

Nutraceutical International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Debt-to-Equity

Get a 7-Day Free Trial

0.26

0.24

0.29

0.20

0.25

Nutraceutical International Quarterly Data
	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17
Debt-to-Equity	Get a 7-Day Free Trial															0.27	0.25	0.22	0.20	0.28

Competitive Comparison of Nutraceutical International's Debt-to-Equity

For the Packaged Foods subindustry, Nutraceutical International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nutraceutical International's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nutraceutical International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nutraceutical International's Debt-to-Equity falls into.

Nutraceutical International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nutraceutical International's Debt to Equity Ratio for the fiscal year that ended in Sep. 2016 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	43.5)	/	171.99
	=	0.25

Nutraceutical International's Debt to Equity Ratio for the quarter that ended in Jun. 2017 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	50.5)	/	182.237
	=	0.28

Nutraceutical International (NAS:NUTR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Nutraceutical International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nutraceutical International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nutraceutical International (Nutraceutical International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nutraceutical International Corp (NAS:NUTR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nutraceutical.com

Nutraceutical International Corp was incorporated in Delaware in 1993. The Company is a manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores. Internationally, it markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Its core business is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns neighborhood natural food markets, which operates under the trade names The Real Food Company, Thom's Natural Foods, Cornucopia Community Market and Granola's. It also owns health food stores, which operates under various trade names, including Fresh Vitamins and Peachtree Natural Foods. The Company's products includes vitamins and minerals, herbs, specialty formulas, personal care products, liquid nutritional products, homeopathics, functional foods and other products.

Executives

J Kimo Esplin	director	C/O NUTRACEUTICAL INTERNATIONAL CORP, 1400 KEARNS BLVD, PARK CITY UT 84060
Bain Capital Investors Llc	10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Iv Lp	10 percent owner	C/O BAIN CAPITAL LLC, TWO COPLEY PLACE, BOSTON MA 02199
Bcip Trust Associates Lp	10 percent owner	C/O BAIN CAPITAL LLC, 111 HUNINGTON AVENUE, BOSTON MA 02199
Robert C Gay	director	C/O BAIN CAPITAL INC TWO COPLEY PLACE, BOSTON MA 02116
Matthew S Levin	director	BAIN CAPITAL PARTNERS LLC JOHN HANCOCK TOWER, 200 CLARENDON STREET BOSTON MA 02116
Associates Bcip	10 percent owner